Oduola Aderonke Aminat (1), Alimi Grace O. Annabelle (2), Ayinde Abayomi. O (3)
Introduction: Human papillomavirus (HPV) and herpes simplex virus type 2 (HSV-2) infections among young female students have become a significant public health concern primarily due to their association with the development of certain cancers, such as cervical, anal, and oropharyngeal cancers.
Objective: This study aimed to determine the prevalence of HPV and HSV-2 infection and explore potential risk factors among this population.
Method of Analysis: A cross-sectional study was conducted among a sample of young female students aged 16 to 25 years residing at Queen Idia Hall, University of Ibadan. The study was approved by the University of Ibadan/University College Hospital Institutional Review Committee (UI/UCH IRC). Data were collected through structured interviews. Vaginal swab sample was collected from 232 study participants. The study was carried out at the department of Virology, UCH, Ibadan. HPV and HSV-2 DNA were detected using polymerase chain reaction (PCR).
Results: HPV DNA was not detected while a low prevalence (6%) of HSV-2 infection was observed among the young female students. Several risk factors were associated with the acquisition of HPV and HSV-2 infections. These included early sexual debut, multiple sexual partners and unprotected sexual intercourse.
Conclusion: The findings of this study indicate absence of HPV infection among the young female students. These results underscore the importance of implementing preventive measures, specifically HPV vaccination, among this particular age group. Given the limited exposure to the virus observed in this study, extending the age range for HPV vaccination is warranted to provide protection against future HPV infection. Efforts should also be directed towards increasing access to screening and early detection of HPV and HSV-2 infections among this population. There is need for comprehensive sexual health education programs targeting young female students, promoting safe sexual practices, and increasing awareness about HPV vaccination.
1. Ryndock, E. J., and Meyers, C. 2014. A risk for nonsexual transmission of human papillomavirus?. Expert review of anti-infective therapy, 12(10), 1165-1170.
2. Helt, A. M., and Galloway, D. A. 2001). Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. Journal of Virology, 75, 6737-6747.
3. Bernard, H. U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., and de Villiers, E. M. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Journal of Virology, 401(1), 70–79.
4. Roman, A., and Munger, K. 2013. The papillomavirus E7 proteins. Virology, 445(1-2), 138-168.
5. Fathi, R., and Tsoukas, M. M. 2014. Genital warts and other HPV infections: Established and novel therapies. Clin Dermatol, 32, 299-306.
6. La Rosa, G. 2016. Papillomavirus. In J. B. Rose and B. Jiménez Cisneros (Eds.), Part 3 Viruses (Meschke, J. S. and Girones, R. (Eds.), Global Water Pathogen Project). Michigan State University. http://www.waterpathogens.org/book/papillomavirus
7. Gallay, C., Miranda, E., Schaefer, S., Catarino, R., Jacot Guillarmod, M., Menoud, P. A., Guerry, F., Achtari, C., Sahli, R., and Vassilakos, P. 2016. Human papillomavirus (HPV) contamination of gynaecological equipment. Sexually Transmitted Infections, 92, 19-23.
8. Boda, D., Neagu, M., Constantin, C., Voinescu, R. N., Caruntu, C., Zurac, S., Spandidos, D. A., Drakoulis, N., Tsoukalas, D., and Tsatsakis, A. M. 2016. HPV strain distribution in patients with genital warts in a female population sample. Oncology Letters, 12, 1779–1782.
9. You, W., Li, S., Du, R., Zheng, J. and Shen, A. 2018. Epidemiological study of high risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening. Experimental and Therapeutic Medicine, 15, 412-418. https://doi.org/10.3892/etm.2017.5424
10. Chesson, H. W., Ekwueme, D. U., Saraiya, M., Dunne, E. F., and Markowitz, L. E. (2011). The cost effectiveness of male HPV vaccination in the United States. Vaccine, 29(46), 8443-8450. https://doi.org/10.1016/journal of vaccine.2011.08.114
11. Ojiyi, E. C., Dike, E. I., Okeudo, C. 2018. Prevalence and predictors of high-risk human papillomavirus infection among women attending routine cervical cancer screening in southeastern Nigeria. Infect Agent Cancer, 13, 32. https://doi.org/10.1186/s13027-018-0204-0
12. Onyekwuluje, J. M., Ogunwale, A. B., Oluwasola, O. A., Fasola, F. A., and Ayoola, O. O. 2020. Prevalence of Human Papillomavirus and its genotypes among women in Nigeria. J Med Virol, 92(11), 3343-3349. https://doi.org/10.1002/jmv.26192
13. ICO/IARC HPV Information Centre, 2023. Institut Català d’Oncologia Avda. Gran Via de l’Hospitalet, 199-20308908 L’Hospitalet de Llobregat (Barcelona, Spain). [email protected].
14. Ryan, K. J., and Ray, C. G. 2004. Sherris Medical Microbiology (4th ed.). McGraw Hill.
15. James C., Harfouche, M., Welton, N. J, Turner, K. M., Abu-Raddad, L. J, Gottlieb, S. L., Looker, K. J. 2020. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. May 1;98(5):315-329. doi: 10.2471/BLT.19.237149. Epub 2020 Mar 25. PMID: 32514197; PMCID: PMC7265941.
16. Schiffer, F., Johnston, A. L., Ravichandran, C., Polcari, A., Teicher, M. H., Webb, R. H., and Hamblin, M. R. 2009. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behavioral and Brain Functions, 5, 46. doi: 10.1186/1744-9081-5-46.
17. Mathew J. J., Sapra A. 2021. Herpes Simplex Type 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, Available from: https://www.ncbi.nlm.nih.gov/books/NBK554427.
18. Burd, E. M. 2003. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 16(1), 1-17. doi: 10.1128/CMR.16.1.1-17.2003.
19. Smith, J. S., Herrero, R., Bosetti, C., Muñoz, N., Bosch, F. X., Eluf-Neto, J., Castellsagué, X., Meijer, C. J., Van den Brule, A. J., Franceschi, S., Ashley, R., and International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group 2002. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. Journal of the National Cancer Institute, 94(21), 1604-1613. doi: 10.1093/jnci/94.21.1604
20. McCloskey, J. C., Kast, W. M., Flexman, J. P., McCallum, D., French, M. A., and Phillips, M. 2017. Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions.
21. Golais, F., and Mrázová, V. 2020. Human alpha and beta herpesviruses and cancer: passengers or foes? Folia Microbiologica, 65(3), 439-449. doi: 10.1007/s12223-020-00780-x.
22. Zhao, Y., Cao, X., Zheng, Y., Tang, J., Cai, W., Wang, H., Gao, Y., and Wang, Y. 2012. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. Journal of Medical Virology, 84(12), 1920-1927. doi: 10.1002/jmv.23353
23. Depuydt, C. E. 2007. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. Journal of Cellular and Molecular Medicine, 11, 881–891. doi: 10.1111/j.1582-4934.2007.00083.
24. Sotlar, K., Diemer, D., Dethleffs, A., Hack, Y., Stubner, A., Vollmer, N., Menton, S., Menton, M., Dietz, K., Wallwiener, D., Kandolf, R., and Bültmann, B. 2004. Detection and typing of human papillomavirus by e6 nested multiplex PCR. Journal of Clinical Microbiology, 42(7), 3176-84. doi: 10.1128/JCM.42.7.3176-3184.2004. PMID: 15243079; PMCID: PMC446280.
25. Ramamurthy, S., Cui, X., Wang, Y., and Vijayendran, R. 2011. Conventional PCR compared to real time PCR for CSF samples. Neurology, 78(1), P01.183.
26. de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., and Bosch, F. X. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
27. Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., and de Sanjosé, S. 2010. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. The Lancet Global Health, 4(7), e453-e463.
28. Nejo, Y. T., Olaleye, D. O., and Odaibo, G. N. 2018. Prevalence and risk factors of genital human papillomavirus infection among women in Southwest, Nigeria. Archives of Basic and Applied Medicine, 6(1), 105-112. doi: 10.4314/abam.v6i1.15
29. Makwe, C. C., Anorlu, R. I., Odeyemi, K. A. 2012. Human papillomavirus (HPV) infection and vaccines: Knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. Journal of Epidemiology and Global Health; 2: 199-206
30. Winer, R. L., Hughes, J. P., Feng, Q., Xi, L. F., Cherne, S., O'Reilly, S. 2010. Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiology, Biomarkers and Prevention, 19(7), 1682–1685. https://doi.org/10.1158/1055-9965.EPI-10-0226
31. Mohamed, Z. K., Alsamarai, A. M., Najem, W. S. 2013. Seroprevalence of Herpes Simplex Virus type 2 (HSV-2) in women with bad obstetric history. American Journal of Dermatology and Venereology.
32. Yunusa, T., Haruna, S. A., and Garba, H. Z. 2019. Seroprevalence of herpes simplex virus among human immunodeficiency virus positive patients in resource-limited setting. Global Journal of Infectious Diseases, 11(3), 107-111.
33. Naga, S., Sarkar, S., Chattopadhyay, D., Bhattacharya, S., Biswas, R., Sen Gupta, M. 2015. Seroprevalence of herpes simplex virus infection in HIV co-infected individuals in Eastern India with Risk Factors Analysis. Advances in Virology. 7. Article ID 537939.
34. Agyemang-Yeboah, F., Oksana, D., Timmy-Donkoh, E., Asmah, R. H., and Mohammed, M. S. 2019. Commentary: Sero-prevalence of herpes simplex virus type 1 and type 2 among women attending routine cervix care clinics in Ghana. Current Findings of Infectious Diseases, (01), RD-INF-10005.
35. Hayatudeen, M. R., Mukhtar, G. L., Aminu, M. 2017. Seroprevalence of immunoglobulins G, M associated with herpes simplex virus type 2 among apparently healthy individuals in Katsina State, Nigeria. UJMR. 2(1):186-191.